Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Diabetes and endocrinology · Diabetes Care · 2026-11-01
RCTn = 6 primary care practices
Donahue et al. From Alert to Action: Electronic Practice Advisory Improves DSMES Referrals Over 18 MonthsDiabetes and endocrinology · Diabetes Care · 2026-11-01
Secondary analysisn = 3,645
Neven et al. Maternal and Neonatal Complications in Pregnant Women With Polyendocrine Metabolic Ovarian Syndrome: A Nested Prospective Cohort StudyDiabetes and endocrinology · Diabetes Care · 2026-11-01
RCTn = 102
Liu et al. Calorie-Restricted DASH, Carbohydrate-Restricted, and Low-Purine Diets for Weight Loss and Urate Control in Men With Overweight or Obesity and Hyperuricemia: A Randomized TrialDiabetes and endocrinology · Diabetes Care · 2026-11-01
RCTn = 91
Hurley et al. Evaluating Improvement in Pain and Sensory Function When Using High-Frequency (10-kHz) Spinal Cord Stimulation in Individuals With Painful Diabetic Neuropathy: A Multicenter Randomized Controlled Trial (PDN-Sensory)Diabetes and endocrinology · N Engl J Med · 2026-10-14
RCTn = 283
Oser et al. Continuous Glucose Monitoring in Non-Insulin-Treated Type 2 DiabetesDiabetes and endocrinology · N Engl J Med · 2026-09-29
RCTn = 2,339
Jastreboff et al. Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of ObesityDiabetes and endocrinology · Lancet · 2026-09-29
RCTn = 1,152
Bellido et al. Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trialDiabetes and endocrinology · Lancet Diabetes Endocrinol · 2026-09-29
RCTn = 493
Garvey et al. Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trialDiabetes and endocrinology · Diabetologia · 2026-09-15
Guideline
Speight et al. 2026 EASD evidence-based clinical practice guideline for assessing and managing diabetes distress among adults with type 1 diabetes or type 2 diabetesDiabetes and endocrinology · Diabetologia · 2026-09-14
Secondary analysisn = 2,150
James et al. Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trialsDiabetes and endocrinology · Diabetologia · 2026-09-11
Meta-analysisn = 55,497
Schipper et al. Interventions to reduce diabetes-related distress among adults with type 1 or type 2 diabetes: a systematic review and meta-analysis of randomised controlled trialsDiabetes and endocrinology · Diabetologia · 2026-09-10
RCTn = 275
Herold et al. Preserving beta cell function in children and adolescents with newly diagnosed stage 3 type 1 diabetes: per-protocol population analysis from the PROTECT randomised trialDiabetes and endocrinology · Diabetologia · 2026-08-29
Meta-analysisn = 983
Choksi et al. Metabolic and macrovascular outcomes following simultaneous pancreas-kidney transplantation and kidney transplantation alone in recipients with type 1 diabetes mellitus: a systematic review and meta-analysisDiabetes and endocrinology · Lancet Diabetes Endocrinol · 2026-08-21
RCTn = 179
Hsia et al. Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trialDiabetes and endocrinology · Diabetologia · 2026-08-19
RCTn = 80
Adly et al. Dulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA)